Synectics (LON:SNX - Get Free Report)'s stock had its "house stock" rating restated by research analysts at Shore Capital in a research report issued on Tuesday,Digital Look reports.
Synectics Trading Down 0.8%
LON:SNX opened at GBX 325 ($4.42) on Tuesday. The company's 50 day moving average is GBX 322.81 and its 200-day moving average is GBX 325.49. The company has a quick ratio of 1.42, a current ratio of 2.02 and a debt-to-equity ratio of 4.04. Synectics has a 12 month low of GBX 161 ($2.19) and a 12 month high of GBX 372 ($5.06). The firm has a market cap of £53.38 million, a price-to-earnings ratio of 18.09 and a beta of 0.69.
Synectics (LON:SNX - Get Free Report) last released its earnings results on Tuesday, July 8th. The company reported GBX 16.40 ($0.22) EPS for the quarter. Synectics had a net margin of 5.63% and a return on equity of 7.67%. Equities analysts anticipate that Synectics will post 1560.0001173 EPS for the current year.
Synectics Company Profile
(
Get Free Report)
Synectics is a global leader in the design, integration, and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets. Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space, custodial and critical infrastructure projects.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synectics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synectics wasn't on the list.
While Synectics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.